chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rash presented 9 days after vaccine  Rash on both arms, both legs, back, and face; rash is very itchy, after scrattching it would sting, it is red, hives were circular, red was all over.  Symptoms are present but improving Was on antibiotic when rash occurred, started taking antb approximetly Feb 13th Benadryl since Saturday the 20th
I63.9 ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 11/28/2022 BLADDER CANCER, UNSPECIFIED SITE I95.9 HYPOTENSION 12/12/2022 BLADDER CANCER, UNSPECIFIED SITE I63.9 ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 11/28/2022 UTI (URINARY TRACT INFECTION) I95.9 HYPOTENSION 12/12/2022 UTI (URINARY TRACT INFECTION) I63.9 ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 11/28/2022 BLADDER CANCER, INVASIVE, UNSPECIFIED SITE I95.9 HYPOTENSION 12/12/2022 BLADDER CANCER, INVASIVE, UNSPECIFIED SITE I63.9 ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 11/28/2022 PELVIC FX, INIT I95.9 HYPOTENSION 12/12/2022 PELVIC FX, INIT
Patient in for office visit. Did not appear nervous at all prior to vaccines. Calm, talkative, and smiling. While patient was sitting on exam table, gave Tdap vaccine in left arm & patient tolerated well. Gave Menactra vaccine in right arm and immediately after withdrawing needle, patient arched her back, fell back on exam table, became unresponsive and pale, very stiff, and arms began jerking. This lasted for less than 30 seconds. When awakened, patient did not remember what happened. Applied cold wet compresses to forehead and neck. Reported she had not anything to eat. Gave a sucker and sips of 7-up and monitored in clinic for 1 hour. Remained alert and oriented, denied any other symptoms.
Came to ED on 4/15 with c/o anginal symptoms, found to be in rapid afib.  EKG showed ST elevation in later precordial leads, went for emergent left heart catheterization.  Went into V-fib arrest requiring defibrillation (x2) in addition to CPR in cath lab.  Angio showed acute thrombotic occlusions of LM, LAD and RI, underwent mechanical thrombectomy of LM and LAD with balloon angio of RI (recent cardiac cath in March 2020 showed clearly patent stents).  Placed on Impella bypass.   Currently in CVICU care, intubated with Impella.
Clients eyes rolled back with body jerking with rigidity for a few seconds followed by going limp with LOC client sat straight up after a few seconds and stated "what happened" became alert and oriented times three PCP notified advised to go to emerg rm for eval. Mother took him directly to emerg rm per mom.
About 30 days after the vaccine, I had a recurrence ("flare") of my ulcerative colitis. This seems somewhat notable as I had been in complete remission (zero symptoms) for 11 years. The flare has been treated with steroids like prednisone, and has waxed and waned, but still had not been brought under control 8 months later.
Syncopal episode found to be massive PE requiring intubation with associated right heart strain (estimated BOVA 4).
Same symptoms as COVID-19 illness but more intense than the disease Headache, myalgias, fever, fatigue, chills Began less than 24 hours following second vaccine and lasted about 24 hours
during the 2nd wk of DEC 11DEC92 pt had high fever 104 & severe weakness for 4-5 days; about 20DEC92 noted difficulty in getting dressed; 24DEC92 difficulty in speaking w/paralysis on lt side of face; dx Bell's palsy; placed of Pred;
report the issue as a PQC.; did not receive the full dose; This case was reported by a nurse via call center representative and described the occurrence of accidental underdose in a 49-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number AB374, expiry date 21st November 2022) for prophylaxis. This case was associated with a product complaint.   Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 13th August 2021, the patient received Boostrix and Boostrix Pre-Filled Syringe Device. On 13th August 2021, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced accidental underdose. On an unknown date, the patient experienced pharmaceutical product complaint. On an unknown date, the outcome of the accidental underdose and pharmaceutical product complaint were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not reported. The nurse reported that the adult patient did not receive the full dose of Boostrix due to an issue, when she was administering the dose 50 percent of the vaccine remained in the syringe, which led to accidental underdose. The reporter consented to follow up. This case has been linked to US2021172420, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021172420:Same reporter
Strong rash resembling shingles, Muscle pain in right back and chest, No outcome, still present.
Information has been received from a registered nurse concerning a patient who on 15-JAN-2007 was vaccinated with a dose of Gardasil that had been improperly stored. It was noted that the patient was not experiencing any symptoms. Unspecified medical attention was sought. No product quality complaint was involved. Follow-up information has been received through the Merck pregnancy registry from a nurse concerning an 18 year old female who on 27-OCT-2006 was vaccinated with Gardasil, when she was 17 1/7 weeks pregnant, LMP 29-JUN-2006, EDD 05-APR-2007). Subsequently, the infant was born with a left club foot and two vessel umbilical cord. The nurse felt that the left club foot and two vessel umbilical cord were other important medical events. Additional information has been requested.
pt admitted to hospital with diagnosis of COVID pneumonia; hypoxemia worsened and pt required intubation; given redesivir, dexamethasone, tocilizumab; condition progressively worsened; comfort measures; extubated and pt died
still has a bruise; itching; then had hives; entire upper arm started to swell; painful; chills; felt like she got stung by a bee; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching), VACCINATION SITE URTICARIA (then had hives), PERIPHERAL SWELLING (entire upper arm started to swell), PAIN (painful) and CHILLS (chills) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to insect sting.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itching), VACCINATION SITE URTICARIA (then had hives), PERIPHERAL SWELLING (entire upper arm started to swell), PAIN (painful), CHILLS (chills) and FEELING ABNORMAL (felt like she got stung by a bee). On 27-Jan-2021, the patient experienced VACCINATION SITE BRUISING (still has a bruise). At the time of the report, VACCINATION SITE PRURITUS (itching), VACCINATION SITE URTICARIA (then had hives), PAIN (painful), CHILLS (chills), FEELING ABNORMAL (felt like she got stung by a bee) and VACCINATION SITE BRUISING (still has a bruise) outcome was unknown and PERIPHERAL SWELLING (entire upper arm started to swell) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
pt recv vax 5OCT98 & 6OCT98 got rash starting on arms has not spread to legs, chest, back & neck;no fever, feels well, no itching, rash red, raised pimply-blotchy, nausea;to call MD;
2 days after administration patient called. Swelling, redness and warm at injection site. About size of patient's hand, on left arm, site of ZOSTAVAX.
Patient fully vaccinated. Chief complaint: Corona virus concerns. Patient presented to the ED with  secondary to worsening migraines and known history of COVID-19. Tested positive four days ago. Patient symptomatic for the past week. Patient suffers from chronic migraines and stated since having COVID-19, her migraines are worse. Patient reported associated cough, nausea, vomiting, headaches and generalized myalgias. Patient also concerned for intermittent chest discomfort. 12-lead EKG ST segments: normal. CXR: no radiographic evidence of acute cardiopulmonary disease. Treatment: Zofran, Toradol, Decadron and Benadryl. Patient instructed to come back to ED if symptoms worsen or situation changes. Discharged from ED.
This spontaneous report was received from a pharmacist via a company representative and refers to six patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On unknown dates, the patients were vaccinated by th epharmacist with PNEUMOVAX23 intramuscularly (dose, anatomical location, lot# and expiration date were not reported) for prevention of pneumococcal disease. On unknown dates, the patients experienced an adverse reaction. Each patient developed an extremely red arm. The patients sought for medical attention. On unknown dates, the patients recovered from the event. The relatedness between the event of extremely red arm and the PNEUMOVAX23 was not reported. Additional information has been requested.
Information was received on 06-OCT-2017 from a lawyer regarding a case in litigation concerning a female patient of unknown age. The patient was inoculated with a dose of ZOSTAVAX vaccine on or about 18-JUL-2013 at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 11-JUL-2016, the patient was treated by a physician for the onset of a severe vesicular rash accompanied by weakened immune systems, which was diagnosed as severe herpes zoster, or shingles. On or about 12-OCT-2016, the patient was treated again by her physician for ongoing and worsening symptoms of shingles infection. The patient has been prescribed VALTREX and nystatin cream (manufacturer unknown) for management of her painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expense, and pain and suffering, and other damages. Additional information has been requested.
2nd dose past 2-6 month recommended time; This non-serious case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too long in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 29th June 2022 in an unknown arm).   On 10-FEB-2023, the patient received the 2nd dose of Shingrix (unknown arm). On 10-FEB-2023, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: 2nd dose past 2-6 month recommended time). The outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK receipt date: 03-MAY-2023 The reporter was the patient and stated that she got her second Shingrix vaccine past the 2 to 6 month recommended time from receiving the first Shingrix vaccine.   The patient did not had any information about the vaccine itself. The reporter did not consent to follow-up. The patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccination schedule.
Nausea, shooting pains throughout body, dizziness (almost passing out), ringing sound in head, fever and chills, weakness, fatigue, soreness at injection site - 15 hours post-injection - took Tylenol. Mild nausea, occasional dizziness, no appetite or thirst, fatigue, weakness, soreness at injection site - 1 day post-injection - no treatment. Mild nausea, occasional dizziness, no appetite or thirst, fatigue, weakness, soreness and blotchy rash at injection site, blotchy rash on sides of neck, chest, tops of arms, and face - 2 days post-injection
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 17Feb2021 as dose 1, single (Lot number: EL9260), on 10Mar2021 as dose 2, single (Lot number: EN6202), on 12Sep2021 as dose 3 (booster), single (Lot number: 3013BA) and on 29Mar2022 as dose 4 (booster), single (Lot number: FK9894) at the age of 40 years for covid-19 immunisation. The patient's relevant medical history included: "Psoriasis" (unspecified if ongoing); "psoriatic arthritis" (unspecified if ongoing); "known allergies: Sulfa" (unspecified if ongoing), notes: Known allergies: Sulfa. The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jun2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (30Jun2022) Negative. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: It was reported that rebound after testing negative post paxlovid.
pt recvd vax; felt immed pain at site & did not feel good immed p/ w/ sl n;12 hrs later,pt found in bathroom eyes rolled back & unconscious; to er; provisional dx: sz; CAT scan nl; referred to neurologist;
Initial unsolicited report received from a non healthcare professional (corrected) on 09 January 2015. A female patient (details not provided), whose medical history and concomitant meidcation was not reported, had received a dose of TDAP, (batch number, dose number, route and site of vaccination were not reported) on an unspecified date. On an unspecified date, patient experienced localized reaction. Illness at the time of vaccination was reported as unknown. Pre-existing physician diagnosed allergies were reported as environmental. Corrective treatment was not reported and laboratory investigations were reported as unknown. At the time of this report, the outcome of the patient was reported as recovered. Documents held by sender: none. Follow up information received from a non healthcare professional (Medical Assistant) on 09-Apr-2015. The patient age was provided as 31 years. The pre-existing physician diagnosed allergies were reported as unknown. There were no laboratory investigations done. It was reported that the information of the reaction was passed on to the facility and they did not administer the vaccine to the patient who had a noted reaction. There was no additional information provided.
Not feeling good; Flu; Wanting to lay down; Slight temperature; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Not feeling good), INFLUENZA (Flu), FATIGUE (Wanting to lay down) and PYREXIA (Slight temperature) in a 75-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal.    On 25-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Not feeling good), INFLUENZA (Flu), FATIGUE (Wanting to lay down) and PYREXIA (Slight temperature). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (Not feeling good), INFLUENZA (Flu), FATIGUE (Wanting to lay down) and PYREXIA (Slight temperature) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: high (High) Slight temperature.         Patient reported that he was on blood pressure medication before receiving the vaccination. Patient reported he experienced little bit of reaction which was not severe.   This case was linked to MOD-2021-367526 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Oct-2021: Follow up received contains no new information.
vaccine given too soon as per CDC guidelines. Called follow up with patient as per parent no adverse reaction pt is doing well notified vaccine given too soon. Made aware to follow up with PCP in 8 weeks.
Sore arm Low grade fever between 101-102 F Really bad body aches Nausea and vomiting that lasted 24 hours Fever has continued in the afternoons
Started feeling nausea, after 3 hours fever rose to 103.0F. Body aches, severe chills and fever.  Could not stand up and walk and had to use urinal. Took Tylenol every 4 hours. Fever broke after eight hours. Next day, low grade fever, weakness and horrific pain at injection site. Could not use or raise arm given the injection.  Third day and out of bed, feeling better.
Pain and heat and hardness in injection site, muscle pain everywhere, tired and weak for 3-4 days, chills shivering and fever for 12hours, upset stomach and nausea for 3 days, intestinal pain and diahrea day 5-6.
My sex drive has gone through the roof. It?s all I think about is sex. I have never had any marital issues until I started thinking about sex ALL THE TIME. I had no drive and it is 100 times worse now. I didn?t want to feel like this. I?ve never felt this way. I?m also more moody than before my vaccination.
Localized erythema, no itching or discomfort reported by patient. Onset 24-48 hrs after immunization.
Patient had mild nausea, BP 120/82 HR100, RR22, no rescue medications required, patient discharged in stable condition
Pt c/o burning of neck-up to eyes felt like she was burning in chest behind eyes and back of neck. Epi given with EMS per pt. Recovered quickly.
Information has been received from a 61 year old female consumer with penicillin, codeine allergies and no pertinent medical history who on 11-APR-2008 was vaccinated in the right arm with zoster vaccine live (Oka/Merck). Subsequently, on 12-APR-2008 the patient developed erythema at the site of injection about the size of a half dollar after administration of the vaccine. The patient also reported that the area is sore to touch. Medical attention was sought, the patient had an office visit. There were no lab studies performed. At the time of the report the patient was recovering. There was no product quality complaint involved. Additional information is not expected.
Vomited, acted dazed, hands limp seemed awake, but confused; t102.8; WBC 11.500;
Patient was given dose #1 of the Pfizer COVID monovalent vaccine 1 day after the beyond use date.
Had a headache following the shot, but was fine for several days after the shot. Then, about a week later: Full body ache, migraine that didn't go away despite taking meds, very tired, feeling of floating and being far away, lethargy, lower back pain, stiff neck, pain in lower skull on either side of head that feels like bad bruising. The bruised feeling has lasted 3 days so far. The far away feeling/tiredness lasted about 6-7 hours and then tapered off. Lesser headache for 2 days after migraine.  Body aches tapered off, but still existing for 3 days.
swollen uvula, throat lymph edema, arm soreness. has history of anaphylaxis
Patient told us on August 21 when she came to pick up her medication that she had pain from the arm up to the neck on the second day after receiving the vaccine. And the pain is still there, but gets better. She is not sure if the pain is due to her carpal tunnel or due to the vaccine.
Fever of 104.5 after booster shot; This spontaneous case was reported by a pharmacist and describes the occurrence of PYREXIA (Fever of 104.5 after booster shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever of 104.5 after booster shot). At the time of the report, PYREXIA (Fever of 104.5 after booster shot) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 104.5 (High) 104.5 degree fahrenheit.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided.
PULMONARY EMBOLISM W INFARCTION, UNSPECIFIED 4/29/2023 PLEURAL EFFUSION ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 4/29/2023 PLEURAL EFFUSION ACUTE RESPIRATORY FAILURE 4/29/2023 PLEURAL EFFUSION ACUTE HYPOXEMIC RESPIRATORY FAILURE 5/2/2023 PLEURAL EFFUSION PULMONARY EMBOLISM W INFARCTION, UNSPECIFIED 4/29/2023 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 4/29/2023 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY ACUTE RESPIRATORY FAILURE 4/29/2023 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY ACUTE HYPOXEMIC RESPIRATORY FAILURE 5/2/2023 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY
if it has been three months since first dose, do I need to take the first dose again; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (if it has been three months since first dose, do I need to take the first dose again) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (if it has been three months since first dose, do I need to take the first dose again). At the time of the report, PRODUCT DOSE OMISSION ISSUE (if it has been three months since first dose, do I need to take the first dose again) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.
Patient complained of severe pain in his left arm. Patient stated he had difficulty lifting his arm. Patient said he can't take ibuprofen because on blood thinner but agreed to take TYLENOL and ice down the arm.
Patient received his second dose of Pfizer vaccine and few minutes upon arrival to post vaccination area, he started to complain of feeling short of  breath and sweating. Vital signs were as follows: 145/94, 85, 98% oxygen. His lungs were clear . Patient told to drink some water and relax. After about 5 minutes, patient began to complain of left arm going numb and unable to swallow water with dry mouth. His vital signs were as follows: 155/107, 92, 99% oxygen, BS 118. Patient denies any swelling of throat or severe shortness of breath. Ambulance was called at this point. Ambulance 9 arrived within 2 minutes and later Medic 8 arrived shortly after that. EKG was performed and wnl, After about 5 minutes patient states he feels better and refuses to go to the hospital. Patient was monitored for another 10 minutes and he was stable, BP 150/100 upon discharge, he denies any shortness of breath or chest pain. He was able to drink water without difficulty. Patient walked out of the clinic with his wife.
"Lethargic" and vomited supplemental formula once.  Reported nursing well, fussy.  The following day resumed normal appetite by 01/05/2005.
Leg pain, limping, fatigue, falling, arm pain, headaches resulting in an ED visit and another subsequent clinic visit for these concerns.